Stable hemoglobin in hemodialysis patients: forest for the trees – a 12-week pilot observational study-Reference-Cited by-同舟云学术

Stable hemoglobin in hemodialysis patients: forest for the trees – a 12-week pilot observational study

Published:2013-11-04 Issue:1 Volume:14 Page:
ISSN:1471-2369
Container-title:BMC Nephrology
language:en
Short-container-title:BMC Nephrol

Author:

Rottembourg Jacques B,Kpade Floride,Tebibel Fadia,Dansaert Aurélie,Chenuc Gaelle

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

http://link.springer.com/article/10.1186/1471-2369-14-243/fulltext.html

Reference39 articles.

1. National Kidney Foundation: NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. Am J Kidney Dis. 1997, 30 (Suppl 3): S192-S230.

2. National Kidney Foundation: NKF-K/DOQI clinical practice guidelines for anemia of chronic kidney diseases: update 2000. Am J Kidney Dis. 2001, 37 (Suppl 1): S182-S238.

3. Locatelli F, Aljama P, Barany P, Canaud B, Carrera F, Eckardt KU, Hörl WH, Macdougal IC, Macleod A, Wiecek A, Cameron S: Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant. 2004, 19 (Suppl 2): ii1-ii47.

4. KDOQI: Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis. 2006, 47: S11-S147.

5. KDOQI: Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease – 2007 update of haemoglobin target. Am J Kidney Dis. 2007, 50: 471-530.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Efficacy and Safety Study of Darbepoetin Alfa versus Epoetin Alfa in Management of Anemia Associated with ESRD in Egyptian Hemodialysis Patients;Current Drug Safety;2021-11-23

2. Time-averaged hemoglobin values, not hemoglobin cycling, have an impact on outcomes in pediatric dialysis patients;Pediatric Nephrology;2018-08-13

3. Utilisation des dérivés injectables du fer au cours de la maladie rénale chronique : intérêts, limites et conseils pour un bon usage;Néphrologie & Thérapeutique;2015-12